// App-Quantinova.ai

3264 : Occurrence of Neoplastic Diseases in a Large Cohort of Thalassemic Patients in Greece

Researchers

Presenter

  • Antonia Chatziliami

Principal Investigators

  • Antonis Kattamis

  • Efthimia Vlachaki

  • Evangelos Briasoulis

  • Ioannis Lafiatis

  • Polyxeni Lampropoulou

  • Christina Fragodimitri

  • Aggeliki Moira

  • Argiris Symeonidis

Medical Centers

  • Hematology Division, Dept of internal Medicine, University Hospital of Patras, Greece, Patras, Greece

  • University of Ioannina School of Medicine, Ioannina, Greece

  • Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece

  • Thalassemia Unit, Vostanio General Hospital of Mytilini, Mytilini, Greece

  • 1st Department of Pediatrics, University of Athens, Athens, Greece

  • Thalassaemia Unit, Hippokration General Hospital Thessaloniki, Thessaloniki, Greece

  • Thalassemia Unit, Agia Sofia Children's Hospital, Athens, Greece

  • Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Acute lymphoblastic leukemia

  • Liver cancer

  • Mucosa-associated lymphoid tissue lymphoma

  • Non-Hodgkin's Lymphoma

  • Mantle cell lymphoma

  • Advanced biliary tract carcinoma

  • Burkitt lymphoma

  • Hodgkin's Lymphoma

  • Renal cell carcinoma

  • Testicular cancer

  • Thyroid Cancer

  • Beta-thalassemia

  • B cell lymphomas

  • Breast cancer

  • Hemochromatosis

  • Hepatitis C

  • Human immunodeficiency virus infection

  • Colorectal Cancer

  • Thalassemia

  • Non‐Hodgkin Lymphoma

  • Solid malignancies

  • Lymphomas

  • Melanoma

  • Teratoma

  • Seminoma

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved